Related Experiment Video
Updated: Feb 5, 2026

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
Published on: June 24, 2021
Global Signaling Profiling in a Human Model of Tumorigenic Progression Indicates a Role for Alternative RNA Splicing
Joseph A Caruso1, Nicholas J Carruthers2, Bryan Thibodeau3
1Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48201, USA. joseph_caruso@wayne.edu.
Abstract:
Intracellular signaling is controlled to a large extent by the phosphorylation status of proteins. To determine how human breast cells can be reprogrammed during tumorigenic progression, we profiled cell lines in the MCF10A lineage by phosphoproteomic analyses. A large cluster of proteins involved in RNA splicing were hypophosphorylated as cells progressed to a hyperplastic state, and then hyperphosphorylated after progression to a fully metastatic phenotype. A comprehensive transcriptomic approach was used to determine whether alterations in splicing factor phosphorylation status would be reflected in changes in mRNA splicing. Results indicated that the degree of mRNA splicing trended with the degree of tumorigenicity of the 4 cell lines tested. That is, highly metastatic cell cultures had the greatest number of genes with splice variants, and these genes had greater fluctuations in expression intensities. Genes with high splicing indices were mapped against gene ontology terms to determine whether they have known roles in cancer. This group showed highly significant associations for angiogenesis, cytokine-mediated signaling, cell migration, programmed cell death and epithelial cell differentiation. In summary, data from global profiling of a human model of breast cancer development suggest that therapeutics should be developed which target signaling pathways that regulate RNA splicing.
Insights
Altered RNA splicing patterns correlate with breast cancer progression. Targeting RNA splicing pathways may offer new therapeutic strategies for breast cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- Protein phosphorylation controls intracellular signaling.
- Understanding breast cancer reprogramming requires profiling signaling changes.
- The MCF10A cell line lineage models human breast cancer development.
Purpose of the Study:
- To investigate how human breast cells reprogram during tumorigenic progression.
- To profile phosphorylation changes in RNA splicing proteins.
- To correlate splicing factor phosphorylation with mRNA splicing alterations and tumorigenicity.
Main Methods:
- Phosphoproteomic analysis of MCF10A cell line lineage.
- Transcriptomic analysis to assess mRNA splicing.
- Gene ontology mapping of genes with high splicing indices.
Main Results:
- Proteins involved in RNA splicing showed altered phosphorylation during breast cancer progression.
- mRNA splicing patterns correlated with the degree of tumorigenicity.
- Genes with altered splicing were significantly associated with cancer-related processes like angiogenesis and cell migration.
Conclusions:
- Aberrant RNA splicing is a hallmark of breast cancer progression.
- Signaling pathways regulating RNA splicing are potential therapeutic targets.
- Further development of therapeutics targeting RNA splicing is warranted for breast cancer treatment.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Chromatin Structure and RNA Splicing
Pre-mRNA Processing: RNA Splicing
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

